Article

Evolution in wavefront-guided treatment yielding improved outcomes

A number of incremental advances that have occurred in wavefront-guided treatment during the past year have added up to significantly enhanced outcomes of these customized procedures, said Capt. Steven C. Schallhorn, MD, director, cornea and refractive surgery, Naval Medical Center, San Diego.

Chicago-A number of incremental advances that have occurred in wavefront-guided treatment during the past year have added up to significantly enhanced outcomes of these customized procedures, said Capt. Steven C. Schallhorn, MD, director, cornea and refractive surgery, Naval Medical Center, San Diego.

These recent developments include faster treatment times that lessen corneal hydration variability and enable better patient fixation; new technology for registration and pupil centroid shift compensation that improve the precision of ablation alignment; improved pulse fidelity; and refined algorithms. In addition, there are benefits available with the use of the femtosecond laser microkeratome for flap creation.

Dr. Schallhorn used data from various studies to illustrate how the various factors have had a positive impact on outcomes. As a final example, he reported data from two groups of patients undergoing wavefront-guided LASIK or wavefront-guided PRK to demonstrate the overall excellent results now achievable with wavefront-guided procedures. Predictability was excellent-in both of the study groups the standard deviation of the refractive error was only about 0.3 D, 90% of eyes had an achieved SE within 0.5 D of intended, and two-thirds were corrected to within 0.25 D of intended. A graph plotting curves of postoperative uncorrected visual acuity (UCVA) minus preoperative best spectacle-corrected visual acuity (BSCVA) showed the distribution was around no change.

“The technology that is available to us now has reduced the variability of refractive outcomes and yields in the average patient, a postop UCVA that is the same as the preop BSCVA. Such results are significantly better than what we were achieving a year ago. However, in the future we can look forward to even better outcomes as progress may be made in aberrometer ergonomics, ablation algorithms, dynamic cyclotorsional tracking, ablation microenvironment control, and even with the development of customized treatments based on individual corneal biomechanics,” Dr. Schallhorn said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.